ESC Professional Premium Access

Monitoring of the lung fluid status in hospitalized COVID-19 patients for predicts outcome. Results of the IMPEDANCE-Corona Trial

Topic: Pathophysiology and Mechanisms

Congress Presentation

About the speaker

Professor Michael Kleiner Shochat

Hillel Yaffe Medical Center, Hadera (Israel)
3 presentations
0 follower

7 more presentations in this session

Risk of worsening heart failure and all-cause mortality following mRNA covid-19 vaccination in patients with heart failure: a Danish nationwide real-world safety study

Speaker: Ms C. Sindet-Pedersen (Hellerup, DK)


Factors of persistent limited exercise tolerance in patients after COVID-19 with normal left ventricular ejection fraction

Speaker: Miss K. Gryglewska-Wawrzak (Lodz, PL)


The impact of pre-existing chronic heart failure on the intensive care treatment and outcome of old intensive care patients suffering from COVID-19

Speaker: Doctor R. Bruno (Duesseldorf, DE)


History of heart failure and chronic kidney disease and the risk for all-cause death after COVID-19 during the three first waves in comparison to influenza outbreaks in Sweden.

Speaker: Doctor V. Ritsinger (Stockholm, SE)


Prognostic value of brain natriuretic peptide in COVID-19 with or without acute heart failure

Speaker: Doctor M. Bergami (Bologna, IT)


Access the full session

Covid-19 and heart failure

Speakers: Professor M. Kleiner Shochat, Ms C. Sindet-Pedersen, Miss K. Gryglewska-Wawrzak, Doctor R. Bruno, Doctor V. Ritsinger...

About the event


ESC Congress 2022

26 August - 29 August 2022

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb